PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424466
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424466
The global renal denervation devices market size was valued at US$ 903.9 million in 2023 and is expected to reach US$ 2,332.1 million by 2030, at a CAGR of 14.5% from 2023 to 2030.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023/2024: | US$ 903.9 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 14.50% | 2030/2031 Value Projection: | US$ 2,332.1 Mn |
Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.
The renal denervation devices market is expected to witness significant growth during the forecast period (2023-2030). Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.
Renal Denervation Devices Market Segmentation